Evidence map›Paper›PMID 35312114›Full record

ArticleJournal of clinical laboratory analysis2022

Analytical and clinical evaluation of the light-initiated chemiluminescent assays for measurement of human thyroid hormones.

Jing Li, Youyuan Huang, Guiming Xiang, Enjun Xu, Tao Chen, Ming Yang, Jie Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jing LiClinical Laboratory, Peking University International Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8197-5963
Youyuan HuangDepartment of Endocrinology, Peking University First Hospital, Beijing, China.
Guiming XiangClinical Laboratory, The Second Affiliated Hospital of Army Medical University, Chongqing, China.
Enjun XuDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Tao ChenClinical Laboratory, Peking University International Hospital, Beijing, China.
Ming YangClinical Laboratory, Peking University International Hospital, Beijing, China.
Jie ZhangClinical Laboratory, Peking University International Hospital, Beijing, China.
Peking University · CNAnhui Medical University · CNArmy Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLight-initiated chemiluminescent assay (LiCA) is a new homogeneous immunoassay. The aim of this study was to evaluate the analytical and clinical performance of the assays for the detection of thyroid hormones based on the fully automated LiCA 800 analyzer.

methodsAnalytical validations of the LiCA thyroid assays (TSH, FT3, FT4, T3, and T4) included precision, linearity, analytical sensitivity, interference, and method comparison applying the protocols of the Clinical and Laboratory Standards Institute (CLSI). The diagnostic performance was assessed by the receiver operating characteristic (ROC) curve analysis with different assay schemes for the diagnosis of hyperthyroidism and hypothyroidism.

resultsWithin-run and within-lab precisions (%CV) of the five assays ranged from 1.06 to 6.40% at all concentrations evaluated. A satisfactory linearity was verified over the entire measuring range for TSH, T3, and T4 (R > 0.99, change in recovery <10%, p = 0.000 all). Paired-comparison measurements presented a comparable assay for each of the five assays (R > 0.96, median bias <5%, p < 0.0001 all) between LiCA and Cobas across three institutes. The diagnostic accuracy of the LiCA assays for hyperthyroidism or hypothyroidism was quantified by the areas under curves (AUC) as 0.925 or 0.832 with the five-assay panel (TSH, FT3, FT4, T3, and T4) and as 0.921 or 0.811 with the three-assay panel (TSH, FT3, and FT4), respectively. No significant difference was found between the AUC of LiCA and that of DxI, Cobas, or Centaur (p > 0.3 all).

conclusionLiCA 800 provides a precise and high-throughput immunoassay platform for detection of thyroid hormones. It is acceptable for clinical use.

Indexed as

HyperthyroidismHypothyroidismHumansLuminescent MeasurementsThyroid HormonesThyrotropinThyroxineTriiodothyronineThyroid HormonesThyrotropinThyroxineTriiodothyronineLiCA 800 analyzerlight-initiated chemiluminescent assayperformance evaluationthyroid assaythyroid disease

Identifiers

PMID35312114
PMCPMC9102509
OpenAlexW4221029296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.